Bitter, István; Lieberman, Jeffrey A; Gaudoux, Florence; Sokoloff, Pierre; Groc, Mélanie; Chavda, Rajeev; Delsol, Cécile; Barthe, Laurence; Brunner, Valérie; Fabre, Carine; Fagard, Marine; Montagne, Agnès; Tonner, Françoise
(2019)
F17464, a highly potent preferential D3 antagonist, is a novel compound in development for schizophrenia treatment. This phase II, double-blind, randomized, placebo-controlled, parallel-group study in five European countries ...